On November 19, 2024, Steven Cosler, a Director at Guardian Pharmacy Services Inc (GRDN, Financial), purchased 7,000 shares of the company. Following this transaction, the insider now owns a total of 17,713 shares. The transaction details can be found in the SEC Filing.
Guardian Pharmacy Services Inc is a company that provides pharmacy services, focusing on delivering medications and consulting services to long-term care facilities. The company operates in a niche market, catering to the specific needs of its clients.
The recent purchase by Steven Cosler is part of a broader trend of insider buying at Guardian Pharmacy Services Inc. Over the past year, the insider has acquired a total of 14,142 shares and has not sold any shares. This activity is consistent with the overall insider transaction history for the company, which shows 5 insider buys and 0 insider sells over the past year.
On the day of the recent purchase, shares of Guardian Pharmacy Services Inc were trading at $21.22 each, resulting in a market cap of $1.346 billion. Investors may consider this insider buying activity as a potential indicator of confidence in the company's future prospects.
For those interested in the valuation metrics, Guardian Pharmacy Services Inc's stock is evaluated using various financial ratios, including the GF Value, price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow. These metrics provide a comprehensive view of the company's financial health and market position.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
